Laddar...
Elucidation and pharmacological targeting of novel molecular drivers of follicular lymphoma progression
Follicular lymphoma (FL), the most common indolent subtype of non-Hodgkin’s lymphoma, is associated with a relatively long overall survival rate ranging from 6 to 10 years from time of diagnosis. However, in 20–60% of FL patients, transformation to aggressive diffuse large B-cell lymphoma (DLBCL) re...
Sparad:
| I publikationen: | Cancer Res |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4738055/ https://ncbi.nlm.nih.gov/pubmed/26589882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-15-0828 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|